Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CHRNA7 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-7 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNA5 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IGF1R Biologics Sequence Review Report 2026: Insulin-like growth factor 1 receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IGF1R protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MET Biologics Sequence Review Report 2026: Hepatocyte growth factor receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MET protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRL2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ADGRL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRL1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ADGRL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
NGF Biologics Sequence Review Report 2026: Beta-nerve growth factor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of NGF protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRB3 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor B3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ADGRB3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PTPRZ1 Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase zeta Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTPRZ1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TGFA Biologics Sequence Review Report 2026: Protransforming growth factor alpha Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TGFA protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TFRC Biologics Sequence Review Report 2026: Transferrin receptor protein 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TFRC protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CR2 Biologics Sequence Review Report 2026: Complement receptor type 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
216
217
218
219
220
>>
1872
>